[{"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; SEVELAMER HCl Tablet, 800 mg may be potentially mislabeled as    RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W002857, EXP: 6/7/2014.", "address_2": "", "product_quantity": "180 Tablets", "code_info": "SEVELAMER HCl Tablet, 800 mg has the following code    Pedigree: W002858, EXP: 6/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SEVELAMER HCl Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 58468002101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-636-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "11 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 07232013@41", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Phenol, 6%, Injectable, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-438-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as    SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) has the following code    Pedigree: AD60590_4, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 51672402701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-602-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DEXAMETHASONE, Tablet, 1 mg may have potentially been mislabeled as the following drug:  VENLAFAXINE HCL ER, Capsule, 150 mg, NDC 00093738656, Pedigree: AD30993_20, EXP: 5/9/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "DEXAMETHASONE, Tablet, 1 mg has the following codes:   Pedigree: AD37088_1, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DEXAMETHASONE, Tablet, 1 mg, Rx only, Distributed by Aidapack Service, LLC, NDC 00054418125.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-798-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PERPHENAZINE, Tablet, 16 mg may have potentially been mislabeled as one of the following drugs:  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD21790_28, EXP: 5/1/2014;  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W002730, EXP: 6/6/2014;  RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: W003680, EXP: 6/25/2014;  VENLAFAXINE HCL", "address_2": "", "product_quantity": "1200 Tablets", "code_info": "PERPHENAZINE, Tablet, 16 mg has the following codes:   Pedigree: AD21790_31, EXP: 5/1/2014;  Pedigree: W002731, EXP: 6/6/2014;  Pedigree: W003682, EXP: 6/25/2014;  Pedigree: AD73525_22, EXP: 5/30/2014;  Pedigree: W003328, EXP: 6/19/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781104901.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-998-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Dallas", "address_1": "4001 McEwen Rd Suite 110", "reason_for_recall": "Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.", "address_2": "", "product_quantity": "285 vials", "code_info": "Lot #s:  N06252012@6 Exp 6/25/13; N01042013@15 Exp 1/29/14; N05072012@3 Exp 2/1/15", "center_classification_date": "20140130", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "HCG (Lyophilized) Stock # 21714, 5000 IUnits-5 mL vial, Compounded by NuVision Pharmacy Dallas, TX 75244", "report_date": "20140205", "classification": "Class I", "openfda": {}, "recalling_firm": "NuVision Pharmacy, Inc.", "recall_number": "D-1051-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64922", "termination_date": "20170208", "more_code_info": "", "recall_initiation_date": "20130415", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MAGNESIUM CHLORIDE, Tablet, 64 mg may be potentially mislabeled as    VITAMIN B COMPLEX W/C, Tablet, NDC 00904026013, Pedigree: AD52993_31, EXP: 5/17/2014;  ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: W003526, EXP: 6/21/2014;  NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001, Pedigree: W002766, EXP: 6/6/2014;  THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedig", "address_2": "", "product_quantity": "720 Tablets", "code_info": "MAGNESIUM CHLORIDE, Tablet, 64 mg has the following codes    Pedigree: AD52993_4, EXP: 5/17/2014;  Pedigree: W003527, EXP: 6/21/2014;  Pedigree: W002712, EXP: 6/6/2014;  Pedigree: W003359, EXP: 6/19/2014;  Pedigree: W003923, EXP: 6/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MAGNESIUM CHLORIDE, Tablet, 64 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 68585000575", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-733-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; CINACALCET HCL Tablet, 60 mg may be potentially mislabeled as    RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W003741, EXP: 6/26/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "CINACALCET HCL, Tablet, 60 mg has the following code    Pedigree: W003742, EXP: 6/26/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CINACALCET HCL Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 55513007430", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-625-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "726.45 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: t10072013@4, 10192013@1, 07112013@3, 09052013@6, 09262013@2, 09272013@35, 10012013@26, 08282013@35, t08282013@17, t10092013@30, t10102013@18, t08222013@11, t08292013@21, t08302013@5, t09162013@30, 09162013@46, 09172013@23, t09242013@33, t09302013@25, t10022013@15, t10112013@21, t10162013@4, t08222013@21, t10092013@29", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "METHYLCOBALAMIN * 10 mg/mL INJECTABLE, METHYLCOBALAMIN * UD/PF 25 mg/mL INJECTABLE, METHYLCOBALAMIN* 1000 mcg/mL INJECTABLE, METHYLCOBALAMIN* 25 mg/mL INJECTABLE, METHYLCOBALAMIN* 5000 mcg/mL INJECTABLE, METHYLCOBALAMIN* PF 1000 mcg/mL PREF SYRINGE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-431-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg may be potentially mislabeled as    traZODone HCl, Tablet, 50 mg, NDC 50111043301, Pedigree: AD37088_4, EXP: 5/9/2014.", "address_2": "", "product_quantity": "135 Tablets", "code_info": "CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg has the following code    Pedigree: AD34928_1, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 11868000901", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-506-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 18 mg, may be potentially mis-labeled as the following drug:    LOVASTATIN, Tablet, 20 mg, NDC 00185007201, Pedigree: AD28369_1, EXP: 5/7/2014.", "address_2": "", "product_quantity": "30 Capsules", "code_info": "ATOMOXETINE HCL, Capsule, 18 mg has the following codes:     Pedigree: AD30140_16, EXP: 5/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATOMOXETINE HCL, Capsule, 18 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002323830.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-767-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Raleigh", "address_1": "2601 Blue Ridge Rd", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All Lots", "center_classification_date": "20140109", "distribution_pattern": "NC", "state": "NC", "product_description": "Papaverine/Phentolamine 30 mg/mL/2.0 mg/mL Inj, 5 mL units Rx Only, The Compounding Center at Blue Ridge, 2601 Blue Ridge Rd, Raleigh, NC 27607.", "report_date": "20140115", "classification": "Class II", "openfda": {}, "recalling_firm": "Compounding Centre At Blue Ridge", "recall_number": "D-405-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66568", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20131018", "postal_code": "27607-6481", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs:  PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: AD30180_4, EXP: 5/8/2014;  OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD49399_4, EXP: 5/16/2014;  ASPIRIN, CHEW Tablet, 81 mg, NDC 00536329736, Pedi", "address_2": "", "product_quantity": "990 Tablets", "code_info": "ATORVASTATIN CALCIUM, Tablet, 10 mg has the following codes:   Pedigree: AD33897_4, EXP: 5/9/2014;  Pedigree: AD49582_7, EXP: 5/16/2014;  Pedigree: W002774, EXP: 6/6/2014;  Pedigree: W003095, EXP: 6/12/2014;", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATORVASTATIN CALCIUM, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378201577.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-900-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mg may have potentially been mislabeled as the following drug:  CAFFEINE, Tablet, 100 mg (1/2 of 200 mg), NDC 24385060173, Pedigree: AD30028_31, EXP: 5/8/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mghas the following codes:   Pedigree: AD28333_4, EXP: 5/6/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378135201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-896-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PROPRANOLOL HCL ER, Capsule, 60 mg may have potentially been mislabeled as the following drug:  CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: AD52778_82, EXP: 5/21/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "PROPRANOLOL HCL ER, Capsule, 60 mg has the following codes:   Pedigree: AD54605_4, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PROPRANOLOL HCL ER, Capsule, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00228277811.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-885-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PHOSPHORUS Tablet, 250 mg may be potentially mislabeled as    CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: AD56921_1, EXP: 5/21/2014;  VENLAFAXINE HCL, Tablet, 75 mg, NDC 00093738201, Pedigree: W002533, EXP: 2/28/2014;  NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg, NDC 47781030701, Pedigree: AD25452_4, EXP: 5/3/2014;  traZODone HCl, Tablet, 50 mg, NDC 50111043303, P", "address_2": "", "product_quantity": "1,000 Tablets", "code_info": "PHOSPHORUS Tablet, 250 mg has the following codes    Pedigree: AD56916_1, EXP: 5/21/2014;  Pedigree: W002534, EXP: 6/3/2014;  Pedigree: AD25452_7, EXP: 5/3/2014;  Pedigree: AD54498_1, EXP: 5/20/2014;  Pedigree: W003997, EXP: 7/1/2014;  Pedigree: AD46300_8, EXP: 5/15/2014;  Pedigree: AD70639_10, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PHOSPHORUS Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980010401", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-699-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "1,140,564 cartons", "code_info": "Lot #: a) 10116014, Exp 6/30/2013; 10122246, Exp 7/31/2013; 10124322, Exp 9/30/2013; 10128122, Exp 11/30/2013; b) 10119852, Exp 7/31/2013; 10122249, Exp 8/31/2013; 10124321, Exp 9/30/2013; 10128118, Exp 11/30/2013; 10128120, Exp 11/30/2013.    NeoCitran Cold & Flu: 10115576, Exp 6/30/2013; 10122243, Exp 8/31/2013 and 10124319, Exp 9/30/2013; Theraflu Exthegran 10115579, 10115572, Exp 6/30/2013; 10117549, Exp 8/30/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "Theraflu (acetaminophen 325 mg, pheniramine maleate 20 mg, phenylephrine hydrochloride 10 mg) powder packets, Natural Lemon flavor, 6-count packets per carton, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ  07054-0622, labeled as a) Theraflu Sinus & Cold (NDC 0067-6319-06, UPC 3 0043-6319-06 7) and b) Theraflu Cold & Sore Throat (NDC 0067-6716-06, UPC 3 0043-0467-16 0).    Also packaged under foreign labels: NeoCitran Cold & Flu powder packets, Natural Source Lemon flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, UPC 0 58478 05009 6; and Theraflu Exthegran powder packets, lemon flavor, packaged in a) 6-count packets per carton (UPC 7 501124 812904) and b) 10-count packets per carton (UPC 7 501124 814588), Distributed by Novartis Farmaceutica S.A. De C.V., Mexico", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-751-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; FEBUXOSTAT Tablet, 40 mg may be potentially mislabeled as    methylPREDNISolone, Tablet, 4 mg, NDC 59746000103, Pedigree: AD21811_17, EXP: 5/1/2014;  tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: W002663, EXP: 6/5/2014;  SODIUM CHLORIDE, Tablet, 1000 mg, NDC 00527111610, Pedigree: W003926, EXP: 7/1/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "FEBUXOSTAT Tablet, 40 mg has the following codes    Pedigree: AD23082_16, EXP: 11/1/2013;  Pedigree: W002664, EXP: 6/5/2014;  Pedigree: W003927, EXP: 7/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FEBUXOSTAT Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64764091830", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-698-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca) may be potentially mislabeled as    VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: W002767, EXP: 6/6/2014;  LACTOBACILLUS ACIDOPHILUS, Capsule, 500 MILLION CFU, NDC 43292050022, Pedigree: AD60240_20, EXP: 5/22/2014;  PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: AD73521_25, EXP: 5/30/2014.", "address_2": "", "product_quantity": "900 Tablets", "code_info": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca) has the following codes    Pedigree: W002699, EXP: 6/5/2014;  Pedigree: AD60240_27, EXP: 5/22/2014;  Pedigree: AD73521_28, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-471-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; HYDRALAZINE HCL Tablet, 25 mg may be potentially mislabeled as    DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: AD49582_16, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "HYDRALAZINE HCL, Tablet, 25 mg has the following code    Pedigree: AD49610_4, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYDRALAZINE HCL Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111032701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-590-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup:NICOTINE POLACRILEX, GUM, 2 mg may have potentially been mislabeled as one of the following drugs:  FOLIC ACID, Tablet, 1 mg, NDC 65162036110, Pedigree: AD33897_22, EXP: 5/9/2014;  QUEtiapine FUMARATE, Tablet, 25 mg, NDC 60505313001, Pedigree: W003099, EXP: 6/13/2014.", "address_2": "", "product_quantity": "1210 Pieces", "code_info": "NICOTINE POLACRILEX, GUM, 2 mg has the following codes:   Pedigree: AD33897_28, EXP: 2/28/2014;  Pedigree: W003100, EXP: 6/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NICOTINE POLACRILEX, GUM, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536302923.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-925-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ITRACONAZOLE, Capsule, 100 mg may be potentially mislabeled as     FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD54549_4, EXP: 5/20/2014.", "address_2": "", "product_quantity": "30 Capsules", "code_info": "ITRACONAZOLE, Capsule, 100 mg has the following code    Pedigree: AD54549_10, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ITRACONAZOLE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 10147170003", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-499-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "New London", "address_1": "170 Broad St", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing", "address_2": "", "product_quantity": "147566", "code_info": "20022 EXP. 12/13, 20031 EXP. 12/13, 20032 EXP. 12/13, 20041 EXP. 12/13, 20042 EXP. 12/13, 20051 EXP. 12/13, 20052 EXP. 12/13, 20061 EXP. 12/13, 20071 EXP. 12/13, 20072 EXP. 12/13", "center_classification_date": "20140205", "distribution_pattern": "Nationwide", "state": "CT", "product_description": "FAMILY wellness Triple Antibiotic Ointment. NET WT 1 OZ (28 g), OTC, DISTRIBUTED BY: FAMILY DOLLAR SERVICES, INC., MATTHEWS,NC 28105", "report_date": "20140212", "classification": "Class II", "openfda": {}, "recalling_firm": "Faria Limited LLC dba Sheffield Pharmaceuticals", "recall_number": "D-1077-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66962", "termination_date": "20140609", "more_code_info": "", "recall_initiation_date": "20131122", "postal_code": "06320-5313", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as the following drug:  PRAMIPEXOLE DI-HCL, Tablet, 1 mg, NDC 16714058701, Pedigree: W003150, EXP: 6/13/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 175 mcg has the following codes:   Pedigree: W003151, EXP: 6/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 175 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378181701", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-899-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA019970"], "brand_name": ["NITROGLYCERIN IN DEXTROSE"], "generic_name": ["NITROGLYCERIN"], "manufacturer_name": ["Baxter Healthcare Company"], "product_ndc": ["0338-1047", "0338-1049", "0338-1051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NITROGLYCERIN"], "rxcui": ["312004", "1868494", "1868562"], "spl_id": ["71811937-e908-4b65-aff2-4b345fa0954b"], "spl_set_id": ["457a026c-ebce-4701-9deb-2d7652759a99"], "package_ndc": ["0338-1047-02", "0338-1049-02", "0338-1051-02"], "is_original_packager": [true], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["G59M7S0WS3"]}, "product_type": "Drugs", "event_id": "66880", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Saudi Arabia and Colombia", "recall_number": "D-1057-2014", "product_description": "50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp., Deerfield, IL --- NDC 0338-1049-02", "product_quantity": "49,932 glass containers", "reason_for_recall": "Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.", "recall_initiation_date": "20131118", "center_classification_date": "20140131", "termination_date": "20140915", "report_date": "20140212", "code_info": "G105197, Exp. 02/14", "more_code_info": ""}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "100 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: t08302013@12", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Sodium tetradecyl SO4, 3% injectable, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-445-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67386", "recalling_firm": "Actavis Inc", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1085-2014", "product_description": "Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 07962, Mfd. by: Debio RP, CH-1920 Martigny, Switzerland.", "product_quantity": "99 cartons", "reason_for_recall": "Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.", "recall_initiation_date": "20131209", "center_classification_date": "20140211", "termination_date": "20140804", "report_date": "20140219", "code_info": "Lot #: 13J081, Exp 05/15"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ESTRADIOL, Tablet, 0.5 mg may have potentially been mislabeled as the following drug:   NICOTINE POLACRILEX, GUM, 2 mg, NDC 00536302923, Pedigree: AD33897_28, EXP: 2/28/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ESTRADIOL, Tablet, 0.5 mg has the following codes:   Pedigree: AD30993_11, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ESTRADIOL, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555089902.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-952-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL LOW IRON Tablet may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00527134601, Pedigree: AD60272_22, EXP: 5/22/2014;  ATORVASTATIN CALCIUM, Tablet, 80 mg, NDC 00378212277, Pedigree: AD73627_1, EXP: 5/30/2014;  MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 37205018581, Pedigree: W002513, EXP: 6/3/2014.", "address_2": "", "product_quantity": "400 Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL LOW IRON Tablet has the following codes    Pedigree: AD60272_31, EXP: 5/22/2014;  Pedigree: AD73627_8, EXP: 5/30/2014;  Pedigree: W002507, EXP: 6/3/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL LOW IRON Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 64376081601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-688-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67118", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "CA, GA, NC, and MO", "recall_number": "D-390-2014", "product_description": "Carisoprodol IV ( Carisoprodol Tablets USP) 350mg, RX only.  Mfd by: Shasun Chemicals Drugs LTD, Pondicherry, INDIA. Repacked and Distributed by: Physicians Total Care, Inc., Tulsa, OK  74146.  90 count bottle: NDC: 54868-0816-8, 60 count bottle: NDC: 54868-0816-4, 30 count bottle: NDC: 54686-0816-3.", "product_quantity": "3,000 tablets", "reason_for_recall": "Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.", "recall_initiation_date": "20131122", "center_classification_date": "20131226", "termination_date": "20160302", "report_date": "20140101", "code_info": "NDC 54868-0816-8, LOT: 6REE,  EXP. 8/14;   NDC 54868-0816-4, LOT: 6RED,  EXP. 8/14;   NDC 54868-0816-3, LOT: 6REB,  EXP. 8/14;", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as    FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: AD21790_52, EXP: 5/1/2014;  FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: W002733, EXP: 6/6/2014;  glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: W003688, EXP: 5/31/2014;  glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: AD30140_34, E", "address_2": "", "product_quantity": "500 Tablets", "code_info": "guaiFENesin ER, Tablet, 600 mg has the following codes    Pedigree: AD21790_58, EXP: 5/1/2014;  Pedigree: W002734, EXP: 6/6/2014;  Pedigree: W003689, EXP: 6/26/2014;  Pedigree: AD30140_37, EXP: 5/7/2014;  Pedigree: W003006, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "guaiFENesin ER Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 45802049878", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-569-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg may have potentially been mislabeled as the following drug:   FLUoxetine HCl, Capsule, 10 mg, NDC 16714035103, Pedigree: W003613, EXP: 6/25/2014.", "address_2": "", "product_quantity": "101 Tablets", "code_info": "HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg has the following codes:   Pedigree: W003614, EXP: 6/25/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYOSCYAMINE SULFATE ODT, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574024701.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-958-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; VENLAFAXINE HCL Tablet, 50 mg may be potentially mislabeled as    sulfaSALAzine, Tablet, 500 mg, NDC 00603580121, Pedigree: AD65475_19, EXP: 5/28/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "VENLAFAXINE HCL Tablet, 50 mg has the following code    Pedigree: AD65475_22, EXP; 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VENLAFAXINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155024801", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-534-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg may have potentially been mislabeled as the following drug:  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD65475_25, EXP: 5/28/2014.  TRI-BUFFERED ASPIRIN, Tablet, 325 mg, NDC 00904201559, Pedigree: W003581, EXP: 6/24/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg has the following codes:  Pedigree: AD65475_13, EXP: 5/28/2014;  Pedigree: W003597, EXP: 6/24/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378041501.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-891-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LANTHANUM CARBONATE Chew Tablet, 500 mg may be potentially mislabeled as    ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD32757_31, EXP: 5/13/2014;  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD32757_53, EXP: 5/14/2014;  MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68585000575, Pedigree: W002712, EXP: 6/6/2014;  MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68", "address_2": "", "product_quantity": "405 Chew Tablets", "code_info": "LANTHANUM CARBONATE, Chew Tablet, 500 mg has the following codes    Pedigree: AD32764_5, EXP: 5/13/2014;  Pedigree: AD32764_8, EXP: 5/14/2014;  Pedigree: W002790, EXP: 6/6/2014;  Pedigree: W003410, EXP: 6/19/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LANTHANUM CARBONATE Chew Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 54092025290", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-615-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "17.5 ml", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 08192013@34, t08272013@34, t10012013@28", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "TESTOS CYPIONATE* IN OLIVE OIL 200 mg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-450-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "30 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: t07312013@36, t09182013@5", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "EDETATE DISODIUM* (0.05M) 1.7% OPHTH SOL, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-418-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: TERBUTALINE SULFATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug:\t  SOTALOL HCL, Tablet, 80 mg, NDC 00093106101, Pedigree: AD52778_85, EXP: 5/21/2014.", "address_2": "", "product_quantity": "101 Tablets", "code_info": "TERBUTALINE SULFATE, Tablet, 2.5 mg has the following codes:   Pedigree: AD52778_88, EXP: 5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TERBUTALINE SULFATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115261101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-859-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: methylPREDNISolone, Tablet, 4 mg may have potentially been mislabeled as the following drug:  OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg, NDC 11523726503, Pedigree: AD42584_15, EXP: 5/14/2014.", "address_2": "", "product_quantity": "299 Tablets", "code_info": "methylPREDNISolone, Tablet, 4 mg may have potentially been mislabeled as the following drug:  OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg, NDC 11523726503, Pedigree: AD42584_15, EXP: 5/14/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "methylPREDNISolone, Tablet, 4 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603459321.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-985-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; QUINAPRIL HCL Tablet, 10 mg may be potentially mislabeled as    PROPRANOLOL HCL, Tablet, 80 mg, NDC 23155011401, Pedigree: AD42566_4, EXP: 5/14/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "QUINAPRIL HCL, Tablet, 10 mg has the following code    Pedigree: AD42611_4, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "QUINAPRIL HCL Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 59762502001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-650-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PROPRANOLOL HCL Tablet, 5 mg (1/2 of 10 mg) may be potentially mislabeled as    LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), NDC 00054002025, Pedigree: AD73525_16, EXP: 5/30/2014.", "address_2": "", "product_quantity": "198 Tablets", "code_info": "PROPRANOLOL HCL, Tablet, 5 mg (1/2 of 10 mg) has the following code    Pedigree: AD73525_25, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PROPRANOLOL HCL Tablet, 5 mg (1/2 of 10 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 23155011001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-530-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ASPIRIN Tablet, 325 mg may be potentially mislabeled as    CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002642, EXP: 6/4/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "ASPIRIN, Tablet, 325 mg has the following code    Pedigree: W002640, EXP: 6/4/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49348000123", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-582-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ASPIRIN EC DR Tablet, 81 mg may be potentially mislabeled as    MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD28322_7, EXP: 5/6/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: W003671, EXP: 6/25/2014.", "address_2": "", "product_quantity": "544 Tablets", "code_info": "ASPIRIN EC DR, Tablet, 81 mg has the following codes    Pedigree: AD28349_1, EXP: 2/28/2014;  Pedigree: W003672, EXP: 2/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN EC DR Tablet, 81 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49348098015", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-585-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "", "code_info": "Lot #: 10122293, Exp 8/31/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "NeoCitran DM Cough & Cold (dextromethorphan hydrobromide 30 mg, phenylephrine hydrochloride 10 mg, pheniramine maleate 20 mg) powder packets, Natural Source Lemon flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, UPC 0 58478 05503 9.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-760-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Voriconazole 0.5mg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1144-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Parsippany", "address_1": "20 Waterview Blvd., Suite 3", "reason_for_recall": "Failed Dissolution Specifications; 12 month acid dissolution test results were above upper limit specifications.", "address_2": "", "product_quantity": "1129 bottles", "code_info": "Lot: #: DM12286, Expiry: 06/14.", "center_classification_date": "20140129", "distribution_pattern": "Nationwide including Puerto Rico", "state": "NJ", "product_description": "Pantaprazole Sodium Delayed Release Tablets , USP 40 mg, 1000 tablets bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India.  Distributed by: Wockhardt USA LLC 20 Waterview Blvd Parsippany, NJ 07054 USA.  NDC: 64679-0434-02.", "report_date": "20140205", "classification": "Class II", "openfda": {}, "recalling_firm": "Wockhardt Usa Inc.", "recall_number": "D-1042-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67238", "termination_date": "20150129", "more_code_info": "", "recall_initiation_date": "20131127", "postal_code": "07054", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Methotrexate Intraocular 400mcg 0.1cc", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1123-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "44.44 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 08222013@3", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Ceftazidime, 22.5 mg/ml (ophthalmic), Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-413-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "180 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: t08162013@15", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Cyanocobalamin, 1000 mcg/ml; injectable, all sizes, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-415-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lynwood", "address_1": "11865 Alameda St", "reason_for_recall": "Presence of Precipitate: Recall is due to complaints of a white substance, confirmed as Guaifenesin, an active ingredient in the product which is precipitating out.", "address_2": "", "product_quantity": "43,921 bottles", "code_info": "Lot #: 151631, Exp 10/15 and 152767, Exp 11/15", "center_classification_date": "20140228", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Tussin CF Adult Maximum Strength Multi-Symptom Cold liquid (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCl 5 mg) per 5 mL, 8 FL OZ (237 mL) bottle, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR  72716, NDC 49035-229-08, UPC 6 81131 03884 3.", "report_date": "20140312", "classification": "Class III", "openfda": {}, "recalling_firm": "Aaron Industries Inc", "recall_number": "D-1097-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "67434", "termination_date": "20141029", "more_code_info": "", "recall_initiation_date": "20140204", "postal_code": "90262-4022", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Earth City", "address_1": "13600 Shoreline Dr", "reason_for_recall": "Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.", "address_2": "", "product_quantity": "111,384 sample packs", "code_info": "Lot  1112467 Exp. 02/15", "center_classification_date": "20140204", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "MO", "product_description": "Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only,  Forest Pharmaceuticals Inc., St. Louis, MO 63045  NDC 0456-3428-05.", "report_date": "20140212", "classification": "Class III", "openfda": {}, "recalling_firm": "Forest Pharmaceuticals Inc", "recall_number": "D-1065-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66838", "termination_date": "20140507", "more_code_info": "", "recall_initiation_date": "20131113", "postal_code": "63045", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "868,104 cartons", "code_info": "Lot #: 10089568, Exp 5/31/2013; 10093324, 10094745, 10097626, 10097627, Exp 7/31/2013; 10098588, Exp 9/30/2013.    NeoCitran Extra Strength Total 7 Symptom Relief Plus Mucous Relief : 10093316, Exp 7/31/2013; 10098591, Exp 9/30/2013; 10101027, Exp 10/31/2013; 10102623, Exp 11/30/2013; 10106813, Exp 1/31/2014; 10115844, Exp 6/30/2014; 10124363, Exp 9/30/2014.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "Theraflu MAX-D Severe  Cold & Flu (acetaminophen 1000 mg, dextromethorphan HBr 30 mg, guaifenesin 400 mg, pseudoephedrine HCl 60 mg) powder packets, Natural Citrus flavor, 6-count packets per carton,  Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ  07054-0622, NDC 0067-6427-06, UPC 3 0067-6427-06 5.    Also packaged under foreign label: NeoCitran Extra Strength Total 7 Symptom Relief Plus Mucous Relief powder packets, Soothing Lemon flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, UPC 0 58478 10701 1.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-753-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; SENNOSIDES Tablet, 8.6 mg may be potentially mislabeled as    SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: AD37063_7, EXP: 5/13/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "SENNOSIDES, Tablet, 8.6 mg has the following code    Pedigree: AD37063_17, EXP: 5/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SENNOSIDES Tablet, 8.6 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 60258095001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-656-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as one of the following drugs:  ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn), NDC 00904533260, Pedigree: AD57624_1, EXP: 5/9/2014;  hydrALAZINE HCl, Tablet, 50 mg, NDC 50111032801, Pedigree: AD52778_28, EXP: 5/20/2014;  CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W003828, EXP: 6/", "address_2": "", "product_quantity": "499 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg has the following codes:   Pedigree: AD60211_1, EXP: 5/21/2014;  Pedigree: AD52778_37, EXP: 5/20/2014;  Pedigree: W003847, EXP: 6/27/2014;  Pedigree: AD30197_13, EXP: 5/9/2014;  Pedigree: AD49423_7, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378181101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-898-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VALSARTAN, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs:  VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD52372_4, EXP: 5/17/2014;  ZINC SULFATE, Capsule, 50 mg, NDC 00904533260, Pedigree: AD30994_8, EXP: 5/9/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "VALSARTAN, Tablet, 40 mg has the following codes:   Pedigree: AD52372_1, EXP: 5/17/2014;  Pedigree: AD32579_1, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VALSARTAN, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078042315.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-819-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; guaiFENesin ER Tablet, 600 mg may be potentially mislabeled as    OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg, NDC 00173078302, Pedigree: W003243, EXP: 6/17/2014.", "address_2": "", "product_quantity": "500 Tablets", "code_info": "guaiFENesin ER, Tablet, 600 mg has the following code    Pedigree: W003244, EXP: 6/17/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "guaiFENesin ER Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63824000850", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-684-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; COLESEVELAM HCL Tablet, 625 mg may be potentially mislabeled as    lamoTRIgine Tablet, 50 mg (1/2 of 100 mg), NDC 13668004701, Pedigree: AD46265_31, EXP: 5/15/2014.", "address_2": "", "product_quantity": "180 Tablets", "code_info": "COLESEVELAM HCL Tablet, 625 mg has the following code    Pedigree: AD46426_19, EXP: 5/15/2014", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "COLESEVELAM HCL Tablet, 625 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65597070118", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-714-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: EFAVIRENZ, Capsule, 200 mg may have potentially been mislabeled as the following drug:  metFORMIN HCl, Tablet\t500 mg, NDC 23155010201, Pedigree: AD46312_25, EXP: 5/16/2014.", "address_2": "", "product_quantity": "90 Capsules", "code_info": "EFAVIRENZ , Capsule, 200 mg has the following codes:   Pedigree: AD46312_31, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "EFAVIRENZ, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00056047492.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-800-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: REPAGLINIDE, Tablet, 2 mg may have potentially been mislabeled as one of the following drugs:  COLCHICINE, Tablet, 0.6 mg, NDC 64764011907, Pedigree: AD46419_1, EXP: 5/16/2014;  PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121207, Pedigree: AD70639_7, EXP: 5/29/2014;  DARUNAVIR, Tablet, 800 mg, NDC 59676056630, Pedigree: W003929, EXP: 7/1/2014.", "address_2": "", "product_quantity": "500 Tablets", "code_info": "REPAGLINIDE, Tablet, 2 mg has the following codes:   Pedigree: AD46419_4, EXP: 5/16/2014;  Pedigree: AD70639_13, EXP: 5/29/2014;  Pedigree: W003925, EXP: 7/1/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "REPAGLINIDE, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00169008481.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-869-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Calcium) may be potentially mislabeled as    tiZANidine HCL, Tablet, 2 mg, NDC 57664050289, Pedigree: W003750, EXP: 6/26/2014.", "address_2": "", "product_quantity": "298 Tablets", "code_info": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Calcium) has the following code    Pedigree: W003720, EXP: 6/26/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Calcium), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-472-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Paramount", "address_1": "16101 Garfield Ave", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found eXtenZone which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine.  Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug.  Dapoxetine is an active ingredient not approved b", "address_2": "", "product_quantity": "2,395 blister packs total for all products", "code_info": "Lot #: KWAKPMC03050517, Exp 12/16", "center_classification_date": "20140130", "distribution_pattern": "CA", "state": "CA", "product_description": "eXtenZone capsules, 1 capsule per blister pack, Distributed by: P.M.C. Company, Buena Park, CA  90621, UPC 6 89076 49126 6.", "report_date": "20140205", "classification": "Class I", "openfda": {}, "recalling_firm": "SS Wholesale Inc. dba Jobbers Wholesale", "recall_number": "D-1047-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66840", "termination_date": "20140509", "more_code_info": "", "recall_initiation_date": "20131118", "postal_code": "90723", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; lamotrigine, Tablet, 50 mg (1/2 of 100 mg) may be potentially mislabeled as    OXYBUTYNIN CHLORIDE, Tablet, 2.5 mg (1/2 of 5 mg), NDC 00603497521, Pedigree: AD73525_64, EXP: 5/30/2014;  FEXOFENADINE HCL, Tablet, 60 mg, NDC 45802042578, Pedigree: AD46257_50, EXP: 5/15/2014.", "address_2": "", "product_quantity": "600 Tablets", "code_info": "lamoTRIgine, Tablet, 50 mg (1/2 of 100 mg) has the following codes    Pedigree: ADWA00002116, EXP: 5/31/2014;  Pedigree: AD46265_31, EXP: 5/15/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "lamoTRIgine, Tablet, 50 mg (1/2 of 100 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 13668004701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-508-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "44 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: t09032013@48, t09252013@37, 09162013@38", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "TRIPLE MIX* 15 mg/1 mg/20 mcg/mL INJECTABLE, TRIPLE MIX* 30 mg/1  mg/20 mcg/mL INJECTABLE (papaverine hydrochloride, phentolamine, prostaglandin), Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-453-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NAPROXEN, Tablet, 500 mg may be potentially mislabeled as    THIOTHIXENE, Capsule, 1 mg, NDC 00378100101, Pedigree: AD54549_22, EXP: 5/20/2014;  HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, NDC 00228282011, Pedigree: AD67989_13, EXP: 5/28/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "NAPROXEN, Tablet, 500 mg has the following codes    Pedigree: AD54516_1, EXP: 5/20/2014;  Pedigree: AD68025_8, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NAPROXEN, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 05374601901", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-495-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; HYDROCHLOROTHIAZIDE Tablet, 12.5 mg may be potentially mislabeled as    chlordiazePOXIDE HCl, Capsule, 25 mg, NDC 00555015902, Pedigree: AD46333_4, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "HYDROCHLOROTHIAZIDE Tablet, 12.5 mg has the following code    Pedigree: AD46414_25, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYDROCHLOROTHIAZIDE Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16729018201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-525-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 50 mg may have potentially been mislabeled as one of the following drugs:  ROSUVASTATIN CALCIUM, Tablet, 5 mg, NDC 00310075590, Pedigree: AD21811_10, EXP: 5/2/2014;  LIOTHYRONINE SODIUM, Tablet, 5 mcg, NDC 42794001802, Pedigree: AD46414_38, EXP: 5/16/2014.", "address_2": "", "product_quantity": "200 Capsules", "code_info": "NORTRIPTYLINE HCL, Capsule, 50 mg has the following codes:  Pedigree:  AD21790_70, EXP: 5/1/2014;  Pedigree:  AD46414_47, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NORTRIPTYLINE HCL, Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-828-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MULTIVITAMIN/MULTIMINERAL, Tablet may be potentially mislabeled as     LISINOPRIL, Tablet, 2.5 mg, NDC 64679092701, Pedigree: AD25264_4, EXP: 5/3/2014.", "address_2": "", "product_quantity": "520 Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL, Tablet has the following code    Pedigree: AD23082_13, EXP: 11/1/2013.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904549213", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-482-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units  may be potentially mislabeled as one of the following drugs:  SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: AD70585_7, EXP: 5/29/2014;  THYROID, Tablet, 60 mg, NDC 00456045901, Pedigree: W002848, EXP: 6/7/2014;  CHOLECALCIFEROL, Tablet, 2000 units, NDC 00904615760, Pedigree: W003744, EXP: 6/26/2014;  amLOD", "address_2": "", "product_quantity": "498 Capsules", "code_info": "PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units  has the following codes:   Pedigree: AD70585_10, EXP: 5/29/2014  Pedigree: W002850, EXP: 6/7/2014;  Pedigree: W003856, EXP: 6/26/2014  Pedigree: AD65457_4, EXP: 5/24/2014;  Pedigree: AD70655_1, EXP: 5/28/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, Rx only, Distributed by: AidaPak Service, LLC,  NDC 00032122401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-785-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Salt Lake City", "address_1": "575/577/579 Chipeta Way", "reason_for_recall": "Subpotent Drug: Drug potency was compromised during shipment.", "address_2": "", "product_quantity": "38,227 Clamshells", "code_info": "Lot #: 514656; Expiry: 03/14", "center_classification_date": "20140225", "distribution_pattern": "Distributed nationwide to physicians as samples.  No military/ govt/ VA or foreign consignees.", "state": "UT", "product_description": "Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only.  Physician sample in clamshell container with seven heat-sealed sachets.  Rx Only.  Watson Pharmaceuticals Inc, Corona, CA, 92890.  NDC: 52544-084-77.", "report_date": "20140305", "classification": "Class III", "openfda": {}, "recalling_firm": "Actavis", "recall_number": "D-1088-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67457", "termination_date": "20140905", "more_code_info": "", "recall_initiation_date": "20140207", "postal_code": "84108-1222", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; FLECAINIDE ACETATE Tablet, 50 mg may be potentially mislabeled as    VITAMIN B COMPLEX W/C, Tablet, NDC 00904026013, Pedigree: AD46419_7, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "FLECAINIDE ACETATE Tablet, 50 mg has the following code    Pedigree: AD46414_16, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FLECAINIDE ACETATE Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162064110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-708-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; BENZOCAINE/MENTHOL Lozenge, 15 mg/3.6 mg may be potentially mislabeled as    LUBIPROSTONE, Capsule, 24 mcg, NDC 64764024060, Pedigree: AD21811_1, EXP: 5/1/2014;  LOSARTAN POTASSIUM, Tablet, 50 mg, NDC 00093736598, Pedigree: W003268, EXP: 6/17/2014.", "address_2": "", "product_quantity": "80 Lozenges", "code_info": "BENZOCAINE/MENTHOL, Lozenge, 15 mg/3.6 mg has the following codes    Pedigree: AD21811_4, EXP: 5/1/2014;  Pedigree: W003273, EXP: 6/17/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BENZOCAINE/MENTHOL Lozenge, 15 mg/3.6 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63824072016", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-685-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "", "code_info": "Lot #: a) 10112236, Exp 4/30/2014 and 10122295, Exp 9/30/2014; b) 10093319, Exp 6/30/2013 and 10100417, Exp 9/30/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "NeoCitran (acetaminophen 1000 mg, pseudoephedrine hydrochloride 60 mg, dextromethorphan hydrobromide 30 mg, chlorpheniramine maleate 4 mg) powder packets, Natural Source Cherry flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, labeled as a) NeoCitran Ultra Strength Total Flu 7 Symptom Relief (UPC 0 58478 47365 9) and b) NeoCitran Extra Strength Sore Throat & Cough (UPC 0 58478 47365 9).", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-758-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LIOTHYRONINE SODIUM Tablet, 25 mcg may be potentially mislabeled as    guanFACINE HCl, Tablet, 1 mg, NDC 00378116001, Pedigree: AD46414_22, EXP: 5/16/2014;  BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00574010603, Pedigree: AD68010_4, EXP: 5/28/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "LIOTHYRONINE SODIUM Tablet, 25 mcg has the following codes    Pedigree: AD46414_35, EXP: 5/16/2014;  Pedigree: AD68010_11, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LIOTHYRONINE SODIUM, Tablet 25 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 42794001902", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-557-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ALLOPURINOL Tablet, 300 mg may be potentially mislabeled as     CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD52993_25, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ALLOPURINOL Tablet, 300 mg has the following code    Pedigree: AD52778_1, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ALLOPURINOL Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714004204", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-515-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Orchard Park", "address_1": "707 Sterling Drive", "reason_for_recall": "Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.", "address_2": "", "product_quantity": "94,080 units Total (432 units held in stock, quarantined)", "code_info": "Stock No: 1086; Case UPC: 3 10742 91086 (5); Item UPC 3 10742 01086 2", "center_classification_date": "20140128", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "ROHTO Redness Relief, ice, Redness Reliever, Lubricant, Astringent Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL).  UPC 3 10742  01086 2,  Manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. for The Mentholatum Company, Orchard Park, NY 14127.   Made in Vietnam.", "report_date": "20140205", "classification": "Class II", "openfda": {}, "recalling_firm": "The Mentholatum Co.", "recall_number": "D-1038-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "67314", "termination_date": "20180601", "more_code_info": "", "recall_initiation_date": "20140116", "postal_code": "14127", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: hydrOXYzine PAMOATE, Capsule, 100 mg may have potentially been mislabeled as one of the following drugs:   CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium), NDC 00904506260, AD46257_43, EXP: 5/15/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: W002734, EXP: 6/6/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: W003689, EXP: 6/26/20", "address_2": "", "product_quantity": "800 Capsules", "code_info": "hydrOXYzine PAMOATE, Capsule, 100 mg has the following codes:   Pedigree: AD46265_28, EXP: 5/15/2014;  Pedigree: W002735, EXP: 6/6/2014;  Pedigree: W003690, EXP: 6/26/2014;  Pedigree: AD21790_61, EXP: 5/1/2014;  Pedigree: AD60272_67, EXP: 5/22/2014;  Pedigree: W003008, EXP: 6/11/2014;  Pedigree: W003332, EXP: 6/18/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "hydrOXYzine PAMOATE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555032402.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-951-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; HYOSCYAMINE SULFATE SL Tablet, 0.125 mg may be potentially mislabeled as    azaTHIOprine, Tablet, 50 mg, NDC 00054408425, Pedigree: AD56832_1, EXP: 5/21/2014;    CHOLECALCIFEROL, Tablet, 1000 units, NDC 00904582460, Pedigree: W003464, EXP: 6/20/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg has the following codes    Pedigree: AD54501_1, EXP: 5/21/2014;  Pedigree: W003438, EXP: 6/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYOSCYAMINE SULFATE SL Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 76439030910", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-735-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DUTASTERIDE, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs:  PHENOL, LOZENGE, 29 mg, NDC 00068021918, Pedigree: AD49582_13, EXP: 5/16/2014;  REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: AD70639_13, EXP: 5/29/2014;  CHOLECALCIFEROL, Capsule, 5000 units, NDC 00904598660, Pedigree: AD52993_22, EXP: 5/20/2014.", "address_2": "", "product_quantity": "90 Capsules", "code_info": "DUTASTERIDE, Capsule, 0.5 mg has the following codes:   Pedigree: AD49610_1, EXP: 5/16/2014;  Pedigree: AD70633_1, EXP: 5/29/2014;  Pedigree: AD52778_4, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DUTASTERIDE, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00173071215.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-873-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NEFAZODONE HCL, Tablet, 150 mg may have potentially been mislabeled as the following drug:  LIOTHYRONINE SODIUM, Tablet, 25 mcg, NDC 42794001902, Pedigree: AD46414_35, EXP: 5/16/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "NEFAZODONE HCL, Tablet, 150 mg has the following codes:   Pedigree: AD46414_41, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NEFAZODONE HCL, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093711306.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-840-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: tiZANidine HCl, Tablet, 2 mg may have potentially been mislabeled as the following drug:  NIACIN TR, Tablet, 500 mg, NDC 00904434260, Pedigree: W002969, EXP: 6/11/2014.", "address_2": "", "product_quantity": "150 Tablets", "code_info": "tiZANidine HCl, Tablet, 2 mg has the following codes:   Pedigree: W002975, EXP: 6/11/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "tiZANidine HCl, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378072219.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-893-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; QUEtiapine FUMARATE Tablet, 100 mg may be potentially mislabeled as    DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: W002776, EXP: 6/6/2014;  NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 37205098769, Pedigree: W003823, EXP: 6/27/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD60578_5, EXP: 5/29/2014.", "address_2": "", "product_quantity": "1,300 Tablets", "code_info": "QUEtiapine FUMARATE, Tablet, 100 mg has the following codes    Pedigree: W002777, EXP: 6/6/2014;  Pedigree: W003825, EXP: 6/27/2014;  Pedigree: AD73623_13, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "QUEtiapine FUMARATE Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505313301", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-665-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs:  BISACODYL EC, Tablet, 5 mg, NDC 00904792760, Pedigree: AD34931_1, EXP: 5/9/2014;  DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071215, Pedigree: AD70633_1, EXP: 5/29/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W002509, EXP: 6/3/2014;  SODIUM CHLORIDE, Tabl", "address_2": "", "product_quantity": "7891 Tablets", "code_info": "SODIUM CHLORIDE, Tablet, 1 mg has the following codes:   Pedigree: AD39560_1, EXP: 5/13/2014;  Pedigree: AD70636_1, EXP: 5/29/2014;  Pedigree: AD73662_1, EXP: 6/3/2014;  Pedigree: W002611, EXP: 6/4/2014;  Pedigree: W003792, EXP: 6/27/2014;  Pedigree: AD22845_10, EXP: 5/2/2014;  Pedigree: W003115, EXP: 6/13/2014;  Pedigree: W003707, EXP: 6/25/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SODIUM CHLORIDE, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00223176001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-883-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020734"], "brand_name": ["CLINIMIX"], "generic_name": ["LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0180", "0338-1133", "0338-1089", "0338-1134", "0338-1091", "0338-1137", "0338-1099", "0338-1138", "0338-1101", "0338-0198", "0338-0188", "0338-0194", "0338-0184", "0338-7001", "0338-7003", "0338-7005", "0338-7007", "0338-7009", "0338-7011", "0338-7013", "0338-7015"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALANINE", "ARGININE", "DEXTROSE", "GLYCINE", "HISTIDINE", "ISOLEUCINE", "LEUCINE", "LYSINE", "METHIONINE", "PHENYLALANINE", "PROLINE", "SERINE", "THREONINE", "TRYPTOPHAN", "TYROSINE", "VALINE"], "rxcui": ["800401", "800405", "800416", "800420", "800434", "800438", "800440", "800444"], "spl_id": ["f39f992f-7a22-46f6-9241-f03d349b95d9"], "spl_set_id": ["dccff103-8695-400c-a15d-cc2fd078760a"], "package_ndc": ["0338-1133-03", "0338-1089-04", "0338-1134-03", "0338-1091-04", "0338-1137-03", "0338-1099-04", "0338-1138-03", "0338-1101-04", "0338-0198-01", "0338-0198-06", "0338-0188-01", "0338-0188-06", "0338-0194-01", "0338-0194-04", "0338-0180-01", "0338-0180-06", "0338-0184-01", "0338-0184-04", "0338-7001-01", "0338-7001-06", "0338-7003-01", "0338-7003-04", "0338-7005-01", "0338-7005-06", "0338-7007-01", "0338-7007-04", "0338-7009-01", "0338-7009-06", "0338-7011-01", "0338-7011-04", "0338-7013-01", "0338-7013-06", "0338-7015-01", "0338-7015-04"], "is_original_packager": [true], "nui": ["N0000175780", "M0000922"], "pharm_class_epc": ["Amino Acid [EPC]"], "pharm_class_cs": ["Amino Acids [CS]"], "unii": ["9DLQ4CIU6V", "452VLY9402", "47E5O17Y3R", "42HK56048U", "IY9XDZ35W2", "OF5P57N2ZX", "94ZLA3W45F", "8DUH1N11BX", "HG18B9YRS7", "TE7660XO1C", "AE28F7PNPL", "GMW67QNF9C", "K3Z4F929H6", "2ZD004190S", "04Y7590D77", "4QD397987E"]}, "product_type": "Drugs", "event_id": "67107", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-1160-2014", "product_description": "Clinimix 5/15 sulfite-free (5% Amino Acid in 15% Dextrose) Injection, 2000 mL CLARITY Dual Chamber Container bag, Rx only.  Dist: Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC: 0338-1099-04.", "product_quantity": "7,388 bags", "reason_for_recall": "Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.", "recall_initiation_date": "20131118", "center_classification_date": "20140314", "termination_date": "20160920", "report_date": "20140326", "code_info": "Lot# P285122, Exp 5/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg may be potentially mislabeled as    MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: W003999, EXP: 7/1/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg has the following code    Pedigree: W004005, EXP: 7/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYDROcodone BITARTRATE/ ACETAMINOPHEN Tablet, 7.5 mg/325 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 52544016201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-609-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DOXEPIN HCL Capsule, 150 mg may be potentially mislabeled as    VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD46312_7, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "DOXEPIN HCL, Capsule, 150 mg has the following code    Pedigree: AD46312_10, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOXEPIN HCL Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 49884022201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-587-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Princeton", "address_1": "107 College Rd E", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Out-of-specification results for microbial count were observed at the initial stability interval for Lansoprazole Delayed Release Capsules.", "address_2": "", "product_quantity": "58,656 Bottles", "code_info": "Lot #: a) 79305114A, b) 79305114B, c) 79305114C, d) 79305114D, e) 79305114E, f) 79305114F, Exp 05/2015", "center_classification_date": "20140305", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "a) Walgreens Lansoprazole Delayed Release Capsules, USP 15 mg/Acid Reducer, 14 capsules per Bottle, Dist by Walgreen Company, 200 Wilmot RD Deerfield IL 60015  b) Family Wellness Lansoprazole Delayed Release Capsules, USP 15 mg/Acid Reducer, 14 capsules per Bottle, Distributed by Family Services Inc .10401 Monroe Road, Matthews, NC 28105 USA  c) CVS Pharmacy Lansoprazole Delayed Release Capsules, 15 mg, Acid Reducer, 14 safety sealed capsules per Bottle, Distributed by CVS/pharmacy Inc, One CVS Drive, Woonsocket, 02895  d) CVS Pharmacy Lansoprazole Delayed Release Capsules, 15 mg, Acid Reducer, 28 safety sealed capsules per Bottle, Distributed by CVS/pharmacy Inc, One CVS Drive, Woonsocket, 02895  e) Equate Lansoprazole Delayed-Release Capsules USP, 15 mg Acid Reducer, 14 capsules per Bottle, and 28 capsules per bottle (Twin Pack)Distributed by Wal-mart Stores Inc. Bentonville, AR 72716  f) CVS Pharmacy Lansoprazole Delayed Release Capsules, 15 mg, Acid Reducer, 42 safety sealed capsules per Bottle, Distributed by CVS/pharmacy Inc, One CVS Drive, Woonsocket, 02895", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "recall_number": "D-1146-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67303", "termination_date": "20151120", "more_code_info": "", "recall_initiation_date": "20140103", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Tacrolimus 0.02% opth. (H20-based)", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1135-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg may be potentially mislabeled as    MAGNESIUM GLUCONATE DIHYDRATE, Tablet, 500 mg (27 mg Elemental Magnesium), NDC 60258017201, Pedigree: AD30197_16, EXP: 5/9/2014.", "address_2": "", "product_quantity": "102 Tablets", "code_info": "LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg has the following code    Pedigree: AD30197_19, EXP: 3/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 42192032901", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-555-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "4.4 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 09242013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "FLUOROURACIL* PF  50 mg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-421-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CILOSTAZOL, Tablet, 100 mg may have potentially been mislabeled as the following drug:  TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg, NDC 00591042401, Pedigree: W002900, EXP: 6/10/2014.", "address_2": "", "product_quantity": "63 Tablets", "code_info": "CILOSTAZOL, Tablet, 100 mg has the following codes:   Pedigree: W002931, EXP: 6/10/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CILOSTAZOL, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185022360.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-881-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "67092", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.", "recall_number": "D-1163-2014", "product_description": "0.9% Sodium Chloride Injection, USP, packaged in a) 50 mL Single dose VIAFLEX plastic containers (Product code 2B1308, NDC 0338-0049-31) and b)  100 mL Single dose VIAFLEX plastic containers (Product code 2B1302, NDC 0338-0049-18) and (Product code 2B1309, NDC 0338-0049-38), Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015 USA.", "product_quantity": "716,544 containers", "reason_for_recall": "Presence of Particulate Matter: Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag", "recall_initiation_date": "20131121", "center_classification_date": "20140314", "termination_date": "20160921", "report_date": "20140326", "code_info": "Lot #: a) P297283, Exp 08/14; b) P292326, Exp 04/14; P293993, Exp 05/14; and P293514, Exp 04/14", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; PANTOPRAZOLE SODIUM DR Tablet, 40 mg may be potentially mislabeled as    SENNOSIDES, Tablet, 8.6 mg, NDC 60258095001, Pedigree: AD37063_17, EXP: 5/13/2014.", "address_2": "", "product_quantity": "1,001 Tablets", "code_info": "PANTOPRAZOLE SODIUM DR Tablet, 40 mg has the following code    Pedigree: AD37063_10, EXP: 5/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PANTOPRAZOLE SODIUM DR Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64679043402", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-690-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; GALANTAMINE HBR ER, Capsule, 24 mg may be potentially mislabeled as    ESCITALOPRAM, Tablet, 5 mg, NDC 00093585001, Pedigree: W003733, EXP: 6/26/2014.", "address_2": "", "product_quantity": "30 Capsules", "code_info": "GALANTAMINE HBR ER, Capsule, 24 mg has the following code    Pedigree: W003735, EXP: 5/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "GALANTAMINE HBR ER Capsule, 24 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 47335083783", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-574-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LIOTHYRONINE SODIUM, Tablet, 5 mcg may have potentially been mislabeled as one of the following drugs:  LIOTHYRONINE SODIUM, Tablet, 25 mcg, NDC 00574022201, Pedigree: W003152, EXP: 4/30/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "LIOTHYRONINE SODIUM, Tablet, 5 mcg has the following codes:   Pedigree: W003153, EXP: 5/31/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LIOTHYRONINE SODIUM, Tablet, 5 mcg, NDC 00574022001, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574022001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-956-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: POTASSIUM ACID PHOSPHATE, Tablet, 500 mg may have potentially been mislabeled as the following drug:  predniSONE, Tablet, 20 mg, NDC 00591544301, Pedigree: AD56879_5, EXP: 5/21/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "POTASSIUM ACID PHOSPHATE, Tablet, 500 mg has the following codes:   Pedigree: AD52778_34, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "POTASSIUM ACID PHOSPHATE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00486111101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-917-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs:  COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD32325_4, EXP: 5/9/2014;  ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: AD49582_7, EXP: 5/16/2014.", "address_2": "", "product_quantity": "811 Tablets", "code_info": "ATORVASTATIN CALCIUM, Tablet, 20 mg has the following codes:   Pedigree: AD33897_7, EXP: 5/9/2014;  Pedigree: AD49582_10, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATORVASTATIN CALCIUM, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378201777.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-901-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Vit A (olive oil) 0.1% opth.", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1141-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "600 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 10032013@2, 10032013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "POTASSIUM PHOSPHATE* PF 4.4 MEQ (3MM)/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-441-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Folic acid (pf) 10mg/cc inj", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1114-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MISOPROSTOL Tablet, 100 mcg may be potentially mislabeled as     QUINAPRIL HCL, Tablet, 10 mg, NDC 59762502001, Pedigree: AD42611_4, EXP: 5/14/2014.", "address_2": "", "product_quantity": "120 Tablets", "code_info": "MISOPROSTOL, Tablet, 100 mcg has the following code    Pedigree: AD42611_7, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MISOPROSTOL Tablet, 100 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43386016012", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-564-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]